Protalix BioTherapeutics (PLX) Treasury Shares (2012 - 2025)

Protalix BioTherapeutics' Treasury Shares history runs 10 years deep, the most recent figure standing at $739594.0 for Q4 2025.

• In Q4 2025, Treasury Shares fell 14.28% year-over-year to $739594.0; the TTM figure through Dec 2025 stood at $739594.0 (down 14.28% YoY), while the FY2025 annual figure was $739594.0, down 14.28% from the prior year.
• Treasury Shares was $739594.0 for Q4 2025 at Protalix BioTherapeutics, down from $862816.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.2 million in Q4 2023 to a low of $291474.0 in Q4 2022.
• Historically, Treasury Shares has averaged $705116.2 across 5 years, with a median of $739594.0 in 2025.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares slumped 36.36% in 2022, then surged 302.67% in 2023.
• A 5-year view of Treasury Shares shows it stood at $458027.0 in 2021, then plunged by 36.36% to $291474.0 in 2022, then soared by 302.67% to $1.2 million in 2023, then fell by 26.49% to $862816.0 in 2024, then declined by 14.28% to $739594.0 in 2025.
• The last three Treasury Shares figures came in at $739594.0 (Q4 2025), $862816.0 (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.